Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Carcinogenesis|March 8, 2007
Targeting survivin in cancer therapy: fulfilled promises and open questionsMarzia Pennati, Marco Folini, Nadia Zaffaroni
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAsNadia Zaffaroni, Marzia Pennati, Marco Folini
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targetsMarco Folini, Marzia Pennati, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets|March 20, 2008
Targeting survivin in cancer therapyMarzia Pennati, Marco Folini, Nadia Zaffaroni
Journal of Cellular and Molecular Medicine|June 21, 2005
Survivin as a target for new anticancer interventionsNadia Zaffaroni, Marzia Pennati, Maria Grazia Daidone
Current Drug Targets|March 18, 2015
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer DrugsMarzia Pennati, Marco Folini, Paolo Gandellini, et al.
Critical Reviews in Oncogenesis|December 6, 2016
Strategies to Strike Survival Networks in CancerMarzia Pennati, Graziella Cimino-Reale, Laura Gatti, et al.
Cellular and Molecular Life Sciences : CMLS|March 14, 2016
Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approachesValentina Doldi, Marzia Pennati, Barbara Forte, et al.
Current Topics in Medicinal Chemistry|December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapyMarzia Pennati, Enrico Millo, Paolo Gandellini, et al.
European Journal of Medicinal Chemistry|August 31, 2017
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agentsGiovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
Pageof 5